Equipoise 200 (Boldenone Undecylenate)

Description

Equipoise 200 is 200mg/mL of Boldenone Undecylenate — the undisputed benchmark for lean mass, endurance enhancement, and appetite stimulation in a long-acting injectable. Originally developed as a veterinary testosterone derivative, Equipoise found its place in performance pharmacology through its distinctive combination: steady, quality lean mass accumulation, dramatic increases in red blood cell production and haematocrit that translate directly to cardiovascular endurance, and an aromatisation rate approximately 50% of testosterone that produces manageable oestrogen without aggressive AI requirements. At 200mg/mL, this formulation hits the industry-standard dose in a single millilitre. The undecylenate ester provides a 14-day half-life — making once-weekly dosing sufficient but requiring 16+ week cycles to fully capitalise on the compound’s slow-building but durable gains. The appetite increase Equipoise produces is well-documented and practically useful in mass phases. Verified at 99%+ purity by Puralytix. Once weekly injection at 400–600mg (2–3mL) is the standard protocol. At this dose range, the increase in RBC and haematocrit becomes clinically significant — regular haematocrit monitoring is recommended. AI management is required given partial aromatisation. Front-loading the first 2 weeks of a cycle accelerates onset toward therapeutic plasma levels.